Skip to main content
SpringerLink
Log in

Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Advances in the identification and treatment of breast and ovarian cancer have lead to a need for reliable estimates of susceptibility risk associated with these two cancers. These estimates may be used in clinical settings to identify individuals at increased risk of developing disease or of being a carrier of a disease susceptibility allele. Accurate assessment of these probabilities is important given the potential implications for medical decision-making including the identification of patients who might benefit from preventive measures, genetic counseling or from entry into clinical trials. A wide range of empirical and statistical models has been proposed, particularly for breast cancer risk prediction, including those that utilize logistic regression or Bayesian modeling. The specific data used to create the various risk models also varies and may include molecular, epidemiologic, or clinical information. This overview presents definitions of risk used in clinical oncology as well as several of the more frequently used methods of risk estimation for breast and ovarian cancer. In addition, the means by which different methods are able to provide a measure of error or uncertainty associated with a given risk estimate will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Am J Epidemiol 1990; 12: 228-40.

    Google Scholar 

  2. Ottman R, Pike MC, King MC et al. Familial breast cancer in a population based series. Am J Epidemiol 1986; 123: 15-21.

    Google Scholar 

  3. Anderson DE, Badzioch MD. Risk of familial breast cancer. Cancer 1985; 56: 383-7.

    Google Scholar 

  4. Sattin RW, Rubin GL, Webster LA et al. Family history and risk of breast cancer. JAMA 1985; 253: 1908-13.

    Google Scholar 

  5. Schwartz AG, King MC, Belle SH et al. Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985; 75: 665-8.

    Google Scholar 

  6. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk: the Utah Population Database. JAMA 1994; 270: 1563-8.

    Google Scholar 

  7. Colditz GA, Willett WC, Hunter DJ et al. Family history, age, and risk of breast cancer. JAMA 1993; 270: 338-43.

    Google Scholar 

  8. Claus EB, Risch N, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131: 961-72.

    Google Scholar 

  9. Lynch HT, Watson P, Conway T et al. Breast cancer family history as a risk factor for early onset breast cancer. Br Cancer Res Treat 1988; 11: 263-7.

    Google Scholar 

  10. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.

    Google Scholar 

  11. Wooster R, Neuhausen SL, Mangion J et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-90.

    Google Scholar 

  12. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 1991; 48: 232-42.

    Google Scholar 

  13. Gail MH, Brinton LA, Byar DP et al. Projecting individualized probabilities of breast cancer for white females who are being examined annually. JNCI 1989; 81: 1879-86.

    Google Scholar 

  14. Rosner B, Colditz G. Nurses' Health Study. Log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 1996; 88: 359-64.

    Google Scholar 

  15. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurse's Health Study. Amer J Epidemiol 2000; 152(10): 950-64.

    Google Scholar 

  16. Berry DA, Parmigiani G, Sanchez J et al. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997; 89: 227-38.

    Google Scholar 

  17. Parmigiani G, Berry DA, Aguilar O. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Human Genet 1998; 62: 145-58.

    Google Scholar 

  18. Couch FJ, DeShano ML, Blackwood A et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409-15.

    Google Scholar 

  19. Shattuck-Eidens D, Oliphant A, McClure M et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 1997; 278: 1242-50.

    Google Scholar 

  20. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995; 57: 1457-62.

    Google Scholar 

  21. Easton D, Ford D, Bishop DT and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995; 56: 265-71.

    Google Scholar 

  22. Struewing JP, Abeliovich D, Peretz T et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995; 11: 198-200.

    Google Scholar 

  23. Schottenfeld D, Fraumeni JF Jr (eds). Cancer Epidemiology and Prevention, 2nd Edition. New York, NY: Oxford University Press, 1996.

    Google Scholar 

  24. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: The Nurses' Health Study. Am J Epidemiol 1994; 139: 819-35.

    Google Scholar 

  25. Constantino J, Gail MH, Pee D et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI 1998; 90: 1371-88.

    Google Scholar 

  26. Fisher B, Constantino JP, Wickerham DL et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371-88.

    Google Scholar 

  27. Breast Cancer Risk Assessment Tool, National Cancer Institute website. http://bcra.nci.nih.gov.

  28. Pike MC, Krailo MD, Henderson BE et al. Hormonal risk factors, breast tissue age, and the age-incidence of breast cancer. Nature 1983; 303: 767-70.

    Google Scholar 

  29. Moolgavkar SH, Day NE, Stevens RG. Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J Natl Cancer Inst 1980; 65: 559-69.

    Google Scholar 

  30. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer: implications for risk prediction. Cancer 1994; 73: 643-51.

    Google Scholar 

  31. Claus EB, Thompson WD, Risch N. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Br Cancer Res Treat 1993; 28: 115-20.

    Google Scholar 

  32. CancerGene at http://www3.utsouthwestern.edu/cancergene.

  33. The prevalence of deletrious mutations in BRCA2 and BRCA2. Myriad Genetics, Inc., 2001. Available at: http:// www.myriad.com/med/brac/mutptables.html.

  34. Gail MH, Benichou J. Assessing the risk of breast cancer in individuals. In Devita VT, Hellman S, Rosenberg SA (eds), Cancer Prevention. Philadelphia, PA: Lippincott, 1992: 1-15.

    Google Scholar 

  35. Bondy ML, Lustbader ED, Halabi S et al. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994; 86: 620-5.

    Google Scholar 

  36. Vogel V, Mondy M, Halabi S et al. Validation of Gail's breast cancer risk model. Proc ASCO 1993; 12: 167.

    Google Scholar 

  37. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individualized breast cancer risk. J Natl Cancer Inst 1994; 86: 600-7.

    Google Scholar 

  38. Rockhill B, Spiegelman D, Byrne C et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. JNCI 2001; 93: 358-66.

    Google Scholar 

  39. McGuigan KA, Ganz PA, Breant C. Agreement between breast cancer risk estimation methods. J Natl Cancer Inst 1996; 88: 1315-6.

    Google Scholar 

  40. Euhus DM, Smith KC, Robinson L et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. JNCI 2002; 94: 844-51.

    Google Scholar 

  41. Hilsenbeck SG, Wenger CR, Reynolds LP et al. Early results of genetic testing for breast cancer susceptibility. Br Cancer Res Treat 1997; 46: 38.

    Google Scholar 

  42. Hiller EH, Parmigiani G, Berry DA et al. Validity testing of a computer model for calculating carrier probabilities of BRCA1 and BRCA2 mutations. Abstract presented at the 1997 meeting of the ASHG.

  43. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990; 46: 813-26.

    Google Scholar 

  44. Benichou J, Gail MH. Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics 1995; 51: 182-94.

    Google Scholar 

  45. Benichou J, Gail M, Mulvihill JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14: 103-10.

    Google Scholar 

  46. Hoskins KF, Stopfer JE, Calzone KA et al. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995; 273: 577-85.

    Google Scholar 

  47. McTiernan A, Gilligan MA, Redmond C. Assessing individual risk for breast cancer: risky business. J Clin Epidemiol 1997; 50: 547-56.

    Google Scholar 

  48. Offit K, Brown K. Quantitating familial cancer risk: a resource for clinical oncologists. J Clin Oncol 1994; 12: 1724-36.

    Google Scholar 

  49. Biesecker BB, Boehnke M, Calzone K et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993; 269: 1970-74.

    Google Scholar 

  50. Parmigiani G, Berry DA, Iversen E et al. Modeling risk of breast cancer and decisions about genetic testing. Fourth Workshop on Case Studies in Bayesian Statistics. Pittsburgh, PA, September 26-27, 1997.

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA

    Elizabeth B. Claus

Authors
  1. Elizabeth B. Claus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Claus, E.B. Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians. Familial Cancer 1, 197–206 (2001). https://doi.org/10.1023/A:1021135807900

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021135807900

Keywords

Search

Navigation